The role of PET-CT scan with somatostatin analogue labelled with gallium-68 (68Ga-DOTA-TATE PET-CT) in diagnosing patients with disseminated medullary thyroid carcinoma (MTC)

Endokrynologia Polska

Volumn 61, Issue 5, 2010, Pages 507-511

  Palyga, Iwona ^a   Kowalska, Aldona ^a   Ga̧sior Perczak, Danuta ^a   Tarnawska Pierścińska, Małgorzata ^b   Słuszniak, Janusz ^b   Sygut, Jacek ^b   Góźdź, Stanisław ^b  

^a Holycross Cancer Centre   (Poland)

^b HCC   (Poland)

Author keywords

68Ga DOTA TATE; Calcitonin; Medullary thyroid carcinoma; Neoplasm metastasis; Positron emission tomography

Indexed keywords

1,4,7,10 TETRAAZACYCLODODECANE 1,4,7,10 TETRAACETIC ACID; FLUORODEOXYGLUCOSE F 18; GALLIUM 68; SOMATOSTATIN DERIVATIVE;

ADULT; AGED; ARTICLE; BONE SCINTISCANNING; CALCITONIN BLOOD LEVEL; CLINICAL ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DISSEMINATED CANCER; ECHOGRAPHY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; ISOTOPE LABELING; LYMPH NODE DISSECTION; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; THYROID MEDULLARY CARCINOMA; WHOLE BODY SCINTISCANNING;

ADULT; AGED; CALCITONIN; FEMALE; GALLIUM RADIOISOTOPES; HUMANS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; THYROID NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED; TUMOR MARKERS, BIOLOGICAL;

EID: 78649991966     PISSN: 0423104X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Schlumberger M, Pacini F. Chapter 18.8.3 medullary thyroid carcinoma - distant metastases. In: Schlumberger M, Pacini F (ed.). Thyroid Tumors Second Edition. Edition Nucleon, Paris 2003: 329.
2. Elisei R, Bottici V, Luchetti F et al. Impact of routine measurement of serum calcitonin on the diagnosis and outcome of medullary thyroid cancer: experience in 10,864 patients with nodular thyroid disorders., J Clin Endocrinol Metab 2004; 89: 163-168. (Pubitemid 38183876)
3. Kloos RT, Eng C, Evans DB et al. Medullary thyroid cancer: management guidelines of the American Thyroid Association. Thyroid 2009; 19: 565-612.
4. Hoefnagel CA, Delprat CC, Zanin D et al. New radionuclide tracers for the diagnosis and therapy of medullary thyroid carcinoma Clin Nucl Med 1988; 13: 159-165.
5. Sone T, Fukunaga M, Otsuka N et al. Metastatic medullary thyroid cancer: localization with iodine-131 metaiodobenzylguanidine J Nucl Med 1985; 26: 604-608.
6. Modigliani E, Cohen R, Campos JM et al. Prognostic factors for survival and for biochemical cure in medullary thyroid carcinoma: results in 899 patients. The GETC Study Group. Groupe d'étude des tumeurs à calcitonine. Clin Endocrinol (Oxf) 1998; 48: 265-273.
7. Scollo C, Baudin E, Travagli JP et al. Rationale for central and bilateral lymph node dissection in sporadic and hereditary medullary thyroid cancer J Clin Endocrinol Metab 2003; 88: 2070-2075. (Pubitemid 36549878)
8. Kebebew E, Ituarte PH, Siperstein AE et al. Medullary thyroid carcinoma: clinical characteristics, treatment, prognostic factors, and a comparison of staging systems. Cancer 2000; 88: 1139-1148.
9. Schlumberger M, Pacini F. Chapter 18.7.2 medullary thyroid carcinoma - post-operative management. In: Schlumberger M, Pacini F (ed.). Thyroid tumors second edition. Edition Nucleon, Paris 2003: 325.
10. Franc S, Niccoli-Sire P, Cohen R et al.; French Medullary Study Group (GETC). Complete surgical lymph node resection does not prevent authentic recurrences of medullary thyroid carcinoma. Clin Endocrinol (Oxf) 2001; 55: 403-409.
11. Wells SA Jr, Baylin SB, Garni DS et al. Medullary thyroid carcinoma: relationship of method of diagnosis to pathologic staging. Ann Surg 1978; 188: 377-383. (Pubitemid 9018182)
12. Giraudet LA, Ghulzan AA, Auperin A et al. Progression of medullary thyroid carcinoma: assessment with calcitonin and carcinoembryonic antigen doubling times Eur J Endocrinol 2008; 158: 239-246. (Pubitemid 351298542)
13. Papotti M, Kumar U, Volante M et al. Immunohistochemical detection of somatostatin receptor types 1-5 in medullary carcinoma of the thyroid Clin Endocrinol (Oxf) 2001; 54: 641-649.
14. Conry BG., Papathanasiou ND, Prakash PV et al. Comparison of 68Ga-DOTATATE and 18F-fluorodeoxyglucose PET-CT in the detection of recurrent medullary thyroid carcinoma Eur J Nucl Med Mol Imaging 2010; 37: 49-57.